Status:

ACTIVE_NOT_RECRUITING

Surgical or Medical Treatment

Lead Sponsor:

Children's Hospital Medical Center, Cincinnati

Collaborating Sponsors:

Children's Hospital Colorado

Conditions:

Diabetes Mellitus, Type 2

Pediatric Obesity

Eligibility:

All Genders

13-19 years

Phase:

PHASE4

Brief Summary

This study will test the hypothesis that metabolic bariatric surgery will be more effective at providing durable glycemic control and reduce co-morbidities than intensive medical therapy in youth with...

Detailed Description

Youth-onset type 2 diabetes (T2D) leads to early dependence on exogenous insulin and progression of T2D co-morbidities, including dyslipidemia, hypertension, non-alcoholic fatty liver disease and diab...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for the medical or surgical type 2 diabetes groups
  • Age 13-19.9 years of age at time of signing the consent
  • Type 2 diabetes by the American Diabetes Association criteria
  • Negative diabetes-associated antibodies
  • Exclusion Criteria for the medical or surgical type 2 diabetes groups Known type 1 diabetes, maturity onset diabetes of the young (MODY), or secondary diabetes
  • Any chronic oral steroids use within 60 days of enrollment
  • Current pancreatotoxic drugs
  • Chronic kidney or liver disease (except NAFLD or DKD)
  • Pregnancy, breast-feeding or intension of becoming pregnant
  • Prior bariatric surgery
  • History of malignancy
  • Current participation in another clinical trial that may affect study outcomes
  • Other conditions, that in the determination of the study investigator, may interfere with study participation
  • Inclusion Criteria for the Obese control group
  • Age 13-19.9 years of age at time of signing the consent
  • Clinical indication to receive bariatric surgery
  • Exclusion Criteria for the obese control group
  • Known diabetes
  • Any chronic oral steroids use within 60 days of enrollment
  • Current pancreatotoxic drugs
  • Chronic kidney or liver disease (except NAFLD or DKD)
  • Pregnancy, breast-feeding or intension of becoming pregnant
  • Prior bariatric surgery
  • History of malignancy
  • Current participation in another clinical trial that may affect study outcomes
  • Other conditions, that in the determination of the study investigator, may interfere with study participation

Exclusion

    Key Trial Info

    Start Date :

    December 15 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2026

    Estimated Enrollment :

    88 Patients enrolled

    Trial Details

    Trial ID

    NCT04128995

    Start Date

    December 15 2019

    End Date

    December 1 2026

    Last Update

    October 22 2025

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Children's Hospital Colorado

    Aurora, Colorado, United States, 80045

    2

    Lurie Children's Hospital

    Chicago, Illinois, United States, 60611

    3

    Cincinnati Childrens

    Cincinnati, Ohio, United States, 45229